Search

everythinglearnresearchcommunity

for

Search:↓

Identified genes linked to male-pattern baldness may help develop new treatments.

Skin issues are common and important for diagnosing PCOS.

Men's and women's pattern hair loss progress differently, with men showing more hair thinning and women having more widespread hair loss.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Male children's genital development issues can be caused by genetic mutations or environmental factors affecting hormone action.

Mutations in the androgen receptor gene cause different levels of androgen insensitivity, making it hard to create simple tests for the condition.

Finasteride effectively blocks enzyme causing male pattern baldness.

Individuals with this condition often develop male traits and identities at puberty despite being raised as females.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Masculinization in affected individuals occurs gradually after puberty due to hormone changes.

Male pattern baldness is likely caused by multiple genes, not just 5α-reductase genes.

Male pattern baldness is largely genetic, linked to the androgen receptor gene, and may relate to certain health issues.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Men with a family history of hair loss are more likely to experience it themselves, especially if both parents have hair loss.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

AGA more common in men, increases with age, linked to family history, hypertension, dyslipidemia, and smoking.

Damaged hair follicle stem cells can cause permanent hair loss, but understanding their role could lead to new treatments.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

AGA increased yearly, type I most common, and family history and seborrheic dermatitis often linked.

The document concludes that a protein involved in hair growth may link to baldness and that more research is needed on its role in hair loss and skin cancer treatments.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Male-pattern baldness is a natural process with unclear causes, and while Minoxidil can help, the results often aren't satisfactory.

Menopause is a clear hormonal transition in women, while men experience a gradual testosterone decline, with some needing lifestyle changes and targeted therapy.

A woman's severe hormone imbalance after menopause led to finding a rare ovarian tumor, treated by surgery.

Mast cells play a significant role in hair loss conditions like male pattern hair loss and alopecia areata.

Hair loss patterns differ between males and females due to 5 master regulators and JAK-STAT signaling affects hair growth.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.